Drug distributor recalls anxiety drug after wrong med found in a bottle

Connecticut-based Breckenridge Pharmaceutical is recalling a lot of duloxetine after a single tablet of a stomach-upset drug was found in a bottle of the generic anxiety drug.

According to the most recent FDA Enforcement Report, the Berlin, CT, company is voluntarily retrieving 595 bottles after the omeprazole capsule was discovered in the bottle of duloxetine.

The meds were manufactured for Breckenridge in Barcelona, Spain, by Laboratorios Dr. Esteve, the report shows. The recall was initiated late last month.

Pfizer ($PFE) faced a similar situation last year when it recalled more than 100,000 bottles of its antidepressant Effexor XR after a pharmacist discovered a Tikosyn capsule in a bottle of the Effexor XR. Tikosyn treats irregular heartbeats. The company warned at the time that there was the potential for a patient prescribed Effexor XR who took a Tikosyn by mistake to have a fatal reaction.

- here's the recall notice

Suggested Articles

McCallum was hit with a warning letter from the FDA for testing issues with its products and failing to keep appropriate records.

The FDA made public a voluntary recall of sterile injectables made by Coastal Meds of Mississippi, after visible particles were found in some vials.

The FDA hit New Jersey-based CMO Tris Pharma with a warning letter, citing significant violations.